Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): A combined analysis of two phase 3 randomised trials

Bernhard, Jürg

Luo, Weixiu

Ribi, Karin

PUGLISI, Fabio